中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
  2. 上海药物研究所
  3. 中国科学院上海药物研究所
  4. 新药研究国家重点实验室
Rational Design of RNA Demethylase FTO Inhibitors with Enhanced Antileukemia Drug-Like Properties

文献类型：期刊论文

作者Xiao, Pan4,5; Duan, Zongliang5,6; Liu, Zeyu1,5; Chen, Liang1,5; Zhang, Deyan1,4,5; Liu, Lu4,5; Zhou, Chen2; Gan, Jianhua3; Dong, Ze4,5; Yang, Cai-Guang1,4,5,6
刊名JOURNAL OF MEDICINAL CHEMISTRY
出版日期2023-07-07
页码22
ISSN号0022-2623
DOI10.1021/acs.jmedchem.3c00543
通讯作者Dong, Ze(dongze@ucas.ac.cn) ; Yang, Cai-Guang(yangcg@simm.ac.cn)
英文摘要The fat mass and obesity-associated protein (FTO) isan RNA N (6)-methyladenosine (m(6)A) demethylasehighly expressed in diverse cancers including acute myeloid leukemia(AML). To improve antileukemia drug-like properties, we have designed 44/ZLD115, a flexible alkaline side-chain-substituted benzoicacid FTO inhibitor derived from FB23. A combination of structure-activityrelationship analysis and lipophilic efficiency-guided optimizationdemonstrates that 44/ZLD115 exhibits better drug-likenessthan the previously reported FTO inhibitors, FB23 and 13a/Dac85. Then, 44/ZLD115 shows significant antiproliferativeactivity in leukemic NB4 and MOLM13 cell lines. Moreover, 44/ZLD115 treatment noticeably increases m(6)A abundance onthe AML cell RNA, upregulates RARA gene expression,and downregulates MYC gene expression in MOLM13 cells,which are consistent with FTO gene knockdown. Lastly, 44/ZLD115 exhibits antileukemic activity in xenograft micewithout substantial side effects. This FTO inhibitor demonstratespromising properties that can be further developed for antileukemiaapplications.
WOS关键词FAT MASS ; GENE-EXPRESSION ; PROTEIN FTO ; IDENTIFICATION ; METHYLATION ; M(6)A ; DERIVATIVES ; SUBSTRATE
资助项目Instrumentation and Service Center for Molecular Sciences at Westlake University ; National Key Research and Development Program of China[2022YFC2705005] ; National Natural Science Foundation of China[22077133] ; National Natural Science Foundation of China[21725801] ; National Natural Science Foundation of China[92153303] ; Youth Innovation Promotion Association of CAS[2021277]
WOS研究方向Pharmacology & Pharmacy
语种英语
WOS记录号WOS:001022368400001
出版者AMER CHEMICAL SOC
源URL[http://119.78.100.183/handle/2S10ELR8/306385]  
专题新药研究国家重点实验室
通讯作者Dong, Ze; Yang, Cai-Guang
作者单位1.Univ Chinese Acad Sci, Beijing 100049, Peoples R China
2.Chinese Acad Sci, Shanghai Inst Mat Med, Analyt Res Ctr Organ & Biol Mol, Shanghai 201203, Peoples R China
3.Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China
4.Univ Chinese Acad Sci, Hangzhou Inst Adv Study, Sch Pharmaceut Sci & Technol, Hangzhou 310024, Peoples R China
5.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China
6.Nanjing Univ Chinese Med, Coll Pharm, Nanjing 210023, Peoples R China
推荐引用方式
GB/T 7714		 Xiao, Pan,Duan, Zongliang,Liu, Zeyu,et al. Rational Design of RNA Demethylase FTO Inhibitors with Enhanced Antileukemia Drug-Like Properties[J]. JOURNAL OF MEDICINAL CHEMISTRY,2023:22.
APA Xiao, Pan.,Duan, Zongliang.,Liu, Zeyu.,Chen, Liang.,Zhang, Deyan.,...&Yang, Cai-Guang.(2023).Rational Design of RNA Demethylase FTO Inhibitors with Enhanced Antileukemia Drug-Like Properties.JOURNAL OF MEDICINAL CHEMISTRY,22.
MLA Xiao, Pan,et al."Rational Design of RNA Demethylase FTO Inhibitors with Enhanced Antileukemia Drug-Like Properties".JOURNAL OF MEDICINAL CHEMISTRY (2023):22.

入库方式： OAI收割

来源：上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。